| Literature DB >> 27792173 |
Oussama Ahrazem1, Lourdes Gómez-Gómez2, María J Rodrigo3, Javier Avalos4, María Carmen Limón5.
Abstract
Apocarotenoids are carotenoid-derived compounds widespread in all major taxonomic groups, where they play important roles in different physiological processes. In addition, apocarotenoids include compounds with high economic value in food and cosmetics industries. Apocarotenoid biosynthesis starts with the action of carotenoid cleavage dioxygenases (CCDs), a family of non-heme iron enzymes that catalyze the oxidative cleavage of carbon-carbon double bonds in carotenoid backbones through a similar molecular mechanism, generating aldehyde or ketone groups in the cleaving ends. From the identification of the first CCD enzyme in plants, an increasing number of CCDs have been identified in many other species, including microorganisms, proving to be a ubiquitously distributed and evolutionarily conserved enzymatic family. This review focuses on CCDs from plants, algae, fungi, and bacteria, describing recent progress in their functions and regulatory mechanisms in relation to the different roles played by the apocarotenoids in these organisms.Entities:
Keywords: algae; apocarotenoids; bacteria; carotenoid cleavage dioxygenase; fungi; plants
Mesh:
Substances:
Year: 2016 PMID: 27792173 PMCID: PMC5133782 DOI: 10.3390/ijms17111781
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Tridimensional models of 12 carotenoid-cleavage dioxygenases from all the subfamilies included in this review. The VP14 (PBD: 2biwA) structure from maize has been used as a template. (A) Side view of CCDs with β-strands shown in yellow, α-helices in magenta, and loops in grey; (B) Top view rotated 90° towards the viewer from (A); (C) Lateral and top views of CCD2, CCD8, and ACO showing Fe2+ ion in green and histidines in blue. Accession numbers are: VP14: O24592.2, ACOX, P74334; AtCCD1, O65572; AtCCD7, AEC10494.1; AtCCD8, Q8VY26; AtCCD4: O49675; Cao-2, XP001727958.1; CarS, ADU04395.1; CarX, CAH70723.1; CsCCD2L, ALM23547.1; CcCCD4b1, XP006424046; AcaA, 77754.
Enzymatic activity of bacterial apo-carotenoid cleavage oxygenases Diox1 and NosAco showing products to different substrates.
| Substrates | Diox1 | NosAco |
|---|---|---|
| β-apo-4′-carotenal | Retinal | Not detected |
| β-apo-8′-carotenal | Retinal | Retinal |
| β-apo-10′-carotenal | Retinal | Retinal |
| β-apo-12′-carotenal | Retinal | Not detected |
| (3 | 3-OH-retinal | 3R-3-OH-retinal |
| (3 | 3-OH-retinal | 3R-3-OH-retinal |
| Apo-8′-lycopenal | Acycloretinal (slow) | Acycloretinal |
| Apo-10′-lycopenal | No information | Acycloretinal |
| β-apo-8′-carotenol | Retinal | Retinal |
| (3 | 3-OH-retinal | 3-OH-retinal |
| Apo-8′-lycopenol | No information | Acycloretinal |
| 4-oxo-β-apo-8′-carotenal | 4-oxo-retinal (slow) | Not tested |
| References | [ | [ |
: Enzyme cleaves at the C15–C15′ double bond, or equivalent positions.
Enzimatic activity and substrate specificity of different bacterial carotenoid oxygenases.
| Assayed Substrates | Enzymes and Products | ||||||
|---|---|---|---|---|---|---|---|
| β-carotene-oxygenase | NosCCD (NSC1) | MtCCO | NSC3 | NACOX1 | SaCCO | PpCCO | |
| β-apo-8′-carotenal | β-ionone ( | β-apo-13-carotenone ( | β-apo-13-carotenone ( | Apo-12′-carotenal ( | |||
| β-apo-10′-carotenal | β-ionone ( | β | |||||
| 3-OH-β-apo-8′-carotenal | 3-OH-β-ionone ( | 3-OH-β-apo-13-carotenone ( | |||||
| 3-OH-β-apo-10′-carotenal | 3-OH-β-ionone ( | 3-OH-β-apo-13-carotenone ( | |||||
| γ-carotene | β-ionone ( | β-apo-13-carotenone ( | |||||
| β-carotene | 2 × β-cyclocitral ( | Apo-10,10′-apocarotene-dial ( | β-apo-13-carotenone ( | No | No | No (in vitro) | No |
| Zeaxanthin | 2 × hydroxi-β-cyclocitral ( | 3-OH-β-ionone ( | 3-OH-β-apo-13-carotenone ( | No | No | No (in vitro) | Apo-13′-zeaxanthinone ( |
| Lycopene | No | No | poorly | Yes (in vivo) | |||
| Lutein | 3-OH-β-apo-13-carotenone ( | No | |||||
| Echinenone | No | 4-oxo-β-ionone ( | |||||
| Canthaxantin | 2 x 4-oxo-β-ionone ( | Apo-13′-canta-xanthinone ( | |||||
| Astaxanthin | 3-OH-β-ionone ( | Apo-13′-astaxanthinone ( | |||||
| References | [ | [ | [ | [ | [ | [ | [ |
Symbols indicate double bonds where oxygenases cleave. : C7–C8; : C9–C10; : C13–C14; : C15–C15′; : C13′–C14′; : C11′-C12′; : C9′–C10′; : C7′–C8′. When an enzyme cleaves at different positions, the predominant product is indicated in bold. Lack of bold means no product preference or information not available.
Substrates tested and cleaved with a unique oxygenase.
| Substrates | Oxygenase | Products |
|---|---|---|
| β-apo-4′-carotenal | NACOX1 | β-apo-13-carotenone ( |
| 3,3′-dihydroxy-isorenieratene | MtCCO | 3-OH-β-apo-13-carotenone ( |
| Echinenone | NosCCD | Apo-10,10′-apocarotenoid ( |
| Nostoxanthin | PpCCO | Apo-14′-nostoxanthinal ( |
| Hydroxylycopene | PpCCO | Unknown |
| Dihydroxylycopene | PpCCO | Unknown |
| Torulene | NSC3 | Transretinal ( |
| 4,4′-diapotorulene | NSC3 | Apo-14′-diapotorulenal ( |
| 4,4′-diapotorulene-4-al | NSC3 | Apo-10′-diapotorulenal ( |
| 4,4′-diaponeurosporene | NSC3 | Apo-14′-diaponeurosporenal ( |
| 4,4′-diaponeurosporen-4′-al | NSC3 | Apo-14′-diaponeurosporenal ( |
| 4,4′-diaponeurosporen-4′-oic acid | NSC3 | Apo-10′-diaponeurosporenal ( |
| Myxol | NosCCD | 3-OH-β-ionone ( |
| Myxol-2′-fucoside | NosCCD | 3-OH-β-ionone ( |
| 4-ketomyxol-2′-fucoside | NosCCD | 3-OH-4-oxo-β-ionone ( |
| 4-hydroxymyxol-2′-fucoside | NosCCD | 3, 4-OH-β-ionone ( |
Symbols indicate double bonds where oxygenases cleave. : C9=C10; : C13=C14; : C15=C15′; : C13′=C14′; : C11′=C12′; : C9′=C10′; : C7′=C8′.
Figure 2Enzymatic reactions achieved by fungal CCDs. (A) Retinal production from β-carotene by the Cco1 (Ustilago maydis) and CarX (F. fujikuroi) CCDs; (B) β-apo-4′-carotenal production from torulene by the CarT (F. fujikuroi) and Cao-2 (N. crassa) CCDs; (C) β-apo-13-carotenone production from β-carotene by the sequential cleavage by the CarS and AcaA CCDs (P. blakesleeanus). Cleavage sites are shaded and indicated by an arrow.
Figure 3Activity of plant CCD1 and CCD2 subfamilies, showing their divergence in substrate specificity and cleavage sites on the following substrates: (A) ζ-carotene and lycopene; (B) β-carotene; and (C) zeaxantine. Symbols indicate double bonds where oxygenases cleave. : C5–C6; : C7–C8; : C9–C10 and C9′–C10′; : C13–C14; : C13′–C14′; : C11′–C12′.
Functional characterization of CCD4 enzymes.
| Species | Protein | Assay a | Parent Carotenoid | Cleavage Position | Product Detected | References |
|---|---|---|---|---|---|---|
| CCD4 | in planta | β-carotene, Violaxanthin | n.d. | n.d. | [ | |
| in planta | Phytofluene, ζ-carotene | n.d. | n.d. | [ | ||
| in planta (leaf) | Epoxy-β-xanthophylls | C9–C10 or C9′–C10′ | C13-glycosids | [ | ||
| in planta (root) | β-carotene | n.d. | long-chain free apocarotenals (C15 to C30) | [ | ||
| in vitro | Apo-β-caroten-8′-al | C9–C10 | β-ionone | [ | ||
| CCD4_C3 | in planta | α-carotene, δ-carotene | C9–C10 | α-ionone | [ | |
| CCD4a | in vivo and in vitro | β-carotene | C9–C10 (C9′–C10′) | β-ionone | [ | |
| CCD4b1 | in vitro | β-carotene, β-cryptoxanthin, Zeaxanthin, Lutein, α-carotene | C7–C8 or C7′–C8′ | 3-OH-apo-β-8-carotenal, apo-β-8-carotenal (C30); | [ | |
| CCD4 | in vitro and in vivo | β-cryptoxanthin, Zeaxanthin | C7–C8 or C7′–C8′ | 3-OH-apo-β-8-carotenal | [ | |
| CCD4a/b | in vivo | β-carotene, Zeaxanthin | C9–C10 (C9′–C10′) | β-ionone, β-OH-ionone | [ | |
| CCD4c | in vivo | β-carotene | C9–C10 or C9′–C10′ | β-ionone, β-cyclocitral | [ | |
| in planta | C7–C8 or C7′–C8′ | |||||
| in planta | Lutein | C9–C10 | Megastigma-4,6,8-triene (derived from 3-OH-α-ionone) | [ | ||
| CCD4 | in vivo | β-carotene | C9–C10 (C9′–C10′) | β-ionone | [ | |
| CCD4 | in vivo | β-carotene | C9–C10 (C9′–C10′) | β-ionone | [ | |
| CCD4 | in vivo | β-carotene | C9–C10 (C9′–C10′) | β-ionone | [ | |
| in vitro | apo-β-8-carotenal | C9–C10 | β-ionone | [ | ||
| CCD4 | in planta | Violaxanthin | n.d. | n.d. | [ | |
| in vitro and in vivo | β-carotene | C9–C10 or C9′–C10′ | Apo-β-caroten-10′-al; β-ionone | [ | ||
| in vitro | α-carotene, Lutein, Zeaxanthin, β-cryptoxanthin | C9–C10 or C9′–C10′ | 3-OH-β-apo-10′-carotenal, β-apo-10′-carotenal3-OH-ε-apo-10´-carotenal | [ | ||
| CCD4a/b | in vivo | ε-carotene, | C9–C10 (C9′–C10′) | α-ionone, | [ | |
| CCD4a/b | in vivo | Neurosporene | C9′–C10′ | Geranylacetone | [ | |
| CCD4a/b | in vivo | Lycopene | C5–C6 (C5′–C6′) | 6-methyl-5-hepten-2-one | [ | |
| CCD4b | in vivo | ζ-carotene | C9–C10 (C9′–C10′) | α-ionone, Geranylacetone | [ |
a In planta refers to data inferred from changes in carotenoid and/or apocarotenoid profiles in overexpressing or knockout CCD4 mutants; In vivo assay indicates data obtained from bacteria over-accumulating carotenoids and expressing CCD4; in vitro assay refers to enzymatic assays performed with recombinant CCD4 enzyme. n.d. not determined.
Figure 4Biosynthetic pathway of strigolactones (SLs) from β-carotene.